Dysfunctional mitochondrial maintenance: What breaks the circle of life?

Brain

Volumn 135, Issue 1, 2012, Pages 9-11

  Yu Wai Man, Patrick ^a   Chinnery, Patrick F ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; DNA DIRECTED DNA POLYMERASE GAMMA; MITOFUSIN 2; REACTIVE OXYGEN METABOLITE;

AGING; AUTOSOMAL DOMINANT DISORDER; CEREBELLAR ATAXIA; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; GENE MUTATION; HEARING IMPAIRMENT; HEREDITARY MOTOR SENSORY NEUROPATHY; INCLUSION BODY MYOSITIS; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL DNA REPLICATION; MULTIPLE SCLEROSIS; MYOPATHY; NONHUMAN; NOTE; OPTIC NERVE ATROPHY; PARKINSON DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RESPIRATORY CHAIN;

EID: 84856723741     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr352     Document Type: Note

References (27)

1. Alavi MV, Bette S, Schimpf S, Schuettauf F, Schraermeyer U, Wehrl HF, et al. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. Brain 2007; 130: 1029-42. (Pubitemid 47355593)
2. Alavi MV, Fuhrmann N, Nguyen HP, Yu-Wai-Man P, Heiduschka P, Chinnery PF, et al. Subtle neurological and metabolic abnormalities in an Opa1 mouse model of autosomal dominant optic atrophy. Exp Neurol 2009; 220: 404-9.
3. Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissiere A, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 2008; 131: 338-51. (Pubitemid 351197609)
4. Ameur A, Stewart JB, Freyer C, Hagstrom E, Ingman M, Larsson NG, et al. Ultra-deep sequencing of mouse mitochondrial DNA: mutational patterns and their origins. PLoS Genet 2011; 7: e1002028.
5. Baker MR, Fisher KM, Whittaker RG, Griffiths PG, Yu-Wai-Man P, Chinnery PF. Subclinical multisystem neurologic disease in 'pure' OPA1 autosomal dominant optic atrophy. Neurology 2011; 77: 1309-12.
6. Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 2006; 38: 515-7.
7. Bourdon A, Minai L, Serre V, Jais JP, Sarzi E, Aubert S, et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 2007; 39: 776-80. (Pubitemid 46848590)
8. Chan SS, Copeland WC. DNA polymerase gamma and mitochondrial disease: understanding the consequence of POLG mutations. Biochim Biophys Acta 2009; 1787: 312-9.
9. Diaz F, Bayona-Bafaluy MP, Rana M, Mora M, Hao H, Moraes CT. Human mitochondrial DNA with large deletions repopulates organelles faster than full-length genomes under relaxed copy number control. Nucleic Acids Res 2002; 30: 4626-33. (Pubitemid 35331743)
10. Elson JL, Samuels DC, Turnbull DM, Chinnery PF. Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age. Am J Hum Genet 2001; 68: 802-6. (Pubitemid 32202775)
11. Hudson G, Amati-Bonneau P, Blakely EL, Stewart JD, He L, Schaefer AM, et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008; 131: 329-37. (Pubitemid 351197604)
12. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005; 309: 481-4. (Pubitemid 40994689)
13. Longley MJ, Clark S, Yu Wai Man C, Hudson G, Durham SE, Taylor RW, et al. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Hum Genet 2006; 78: 1026-34. (Pubitemid 43787693)
14. Mahad DJ, Ziabreva I, Campbell G, Laulund F, Murphy JL, Reeve AK, et al. Detection of cytochrome c oxidase activity and mitochondrial proteins in single cells. J Neurosci Methods 2009; 184: 310-9.
15. Mandel H, Szargel R, Labay V, Elpeleg O, Saada A, Shalata A, et al. The deoyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 2001; 29: 337-41. (Pubitemid 33096462)
16. Moslemi AR, Lindberg C, Oldfors A. Analysis of multiple mitochondrial DNA deletions in inclusion body myositis. Hum Mutat 1997; 10: 381-6. (Pubitemid 27473299)
17. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999; 283: 689-92.
18. Payne BA, Wilson IJ, Hateley CA, Horvath R, Santibanez-Koref M, Samuels DC, et al. Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations. Nat Genet 2011; 43: 806-10.
19. Rouzier C, Bannwarth S, Chaussenot A, Chevrollier A, Verschueren A, Bonello-Palot N, et al. The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy 'plus' phenotype. Brain 2012; (in press).
20. Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myop-athy. Nat Genet 2001; 29: 342-4. (Pubitemid 33096463)
21. Spelbrink JN, Li FY, Tiranti V, Nikali K, Yuan QP, Wanrooij S, et al. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localised in mitochondria. Nat Genet 2001; 28: 223-31. (Pubitemid 32626024)
22. Trifunovic A, Hansson A, Wredenberg A, Rovio AT, Dufour E, Khvorostov I, et al. Somatic mtDNA mutations cause aging pheno-types without affecting reactive oxygen species production. Proc Natl Acad Sci USA 2005; 102: 17993-8. (Pubitemid 41798490)
23. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, et al. Premature ageing in mice expressing defective mito-chondrial DNA polymerase. Nature 2004; 429: 417-23. (Pubitemid 38715133)
24. Van Goethem G, Dermaut B, Lofgren A, Martin J-J, Van Broeckhoven C. Mutation of POLG is associated with progressive external ophthalmo-plegia characterized by mtDNA deletions. Nat Genet 2001; 28: 211-2. (Pubitemid 32626018)
25. Yu-Wai-Man P, Davies VJ, Piechota MJ, Cree LM, Votruba M, Chinnery PF. Secondary mtDNA defects do not cause optic nerve dysfunction in a mouse model of dominant optic atrophy. Invest Ophthalmol Vis Sci 2009; 50: 4561-6.
26. Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M, et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain 2010; 133: 771-86.
27. Zeviani M, Bresolin N, Gellera C, Bordoni A, Pannacci M, Amati P, et al. Nucleus-driven multiple large-scale deletions of the human mitochon-drial genome: a new autosomal dominant disease. Am J Hum Genet 1990; 47: 904-14. (Pubitemid 120024058)